Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial

被引：0
|
作者：
Li, Shaohua [1 ]
Wei, Wei [1 ]
Wang, Qiaoxuan [1 ]
Guo, Zhixing [1 ]
Mei, Jie [1 ]
Lu, Lianghe [1 ]
Ling, Yihong [1 ]
Xu, Li [1 ]
Chen, Minshan [1 ]
Lin, Wenping [1 ]
Zou, Jingwen [1 ]
Wen, Yuhua [1 ]
Guo, Rongping [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
527
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Transarterial chemoembolization with idarubicin versus epirubicin for hepatocellular carcinoma: An interim analysis of a multicentre, randomized controlled phase III trial
    Zhang, Z.
    Shao, G.
    Yu, C.
    Ji, J.
    Ma, J.
    Guo, X.
    Zhao, Z.
    Shi, C.
    Zhang, H.
    Ji, P.
    Sun, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S607 - S607
  • [32] Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
    Wei, Wei
    Jian, Pei-En
    Li, Shao-Hua
    Guo, Zhi-Xing
    Zhang, Yong-Fa
    Ling, Yi-Hong
    Lin, Xiao-Jun
    Xu, Li
    Shi, Ming
    Zheng, Lie
    Chen, Min-Shan
    Guo, Rong-Ping
    CANCER COMMUNICATIONS, 2018, 38
  • [33] Randomized phase III trial of FOLFOX versus XELOX as adjuvant chemotherapy in patients with early-stage colorectal adenocarcinoma.
    Pectasides, Dimitrios G.
    Papaxoinis, George
    Xanthakis, Ioannis
    Kouvatseas, George
    Kotoula, Vassiliki
    Xiros, Nikolaos
    Samantas, Epaminondas
    Papakostas, Pavlos
    Klouvas, George
    Varthalitis, Ioannis I.
    Pentheroudakis, George E.
    Fountzilas, George
    Bafaloukos, Dimitris
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial
    Guo, Jia
    Bao, Xuli
    Liu, Fuquan
    Guo, Jiang
    Wu, Yifan
    Xiong, Fang
    Lu, Jun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1379 - 1388
  • [35] Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report
    Lee, JH
    Lee, JH
    Ahn, JH
    Bahng, H
    Kim, TW
    Kang, YK
    Lee, KH
    Kim, JC
    Yu, CS
    Kim, JH
    Ahn, SD
    Kim, WK
    Kim, SH
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1751 - 1758
  • [36] Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial
    Nomura, Hiroyuki
    Aoki, Daisuke
    Susumu, Nobuyuki
    Mizuno, Mika
    Nakai, Hidekatsu
    Arai, Masahide
    Nishio, Shin
    Tokunaga, Hideki
    Nakanishi, Toru
    Watanabe, Yoh
    Yaegashi, Nobuo
    Yokoyama, Yoshihito
    Takehara, Kazuhiro
    GYNECOLOGIC ONCOLOGY, 2019, 155 (03) : 413 - 419
  • [37] TRANSARTERIAL EMBOLIZATION (TAE) VS NO TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA (HCC) - PRELIMINARY-RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    CASTELLS, A
    BRUIX, J
    MONTANYA, X
    BRU, C
    AYUSO, MC
    BOIX, L
    RODES, J
    HEPATOLOGY, 1994, 19 (04) : I51 - I51
  • [38] Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
    Peng, Zhenwei
    Fan, Wenzhe
    Zhu, Bowen
    Wang, Guoying
    Sun, Junhui
    Xiao, Chengjiang
    Huang, Fuxi
    Tang, Rong
    Cheng, Yu
    Huang, Zhen
    Liang, Yuchuang
    Fan, Huishuang
    Qiao, Liangliang
    Li, Fuliang
    Zhuang, Wenquan
    Peng, Baogang
    Wang, Jiping
    Li, Jiaping
    Kuang, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 117 - +
  • [39] Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin
    Gish, Robert G.
    Porta, Camillo
    Lazar, Lucian
    Ruff, Paul
    Feld, Ronald
    Croitoru, Adina
    Feun, Lynn
    Jeziorski, Krzysztof
    Leighton, John
    Gallo, Jose
    Kennealey, Gerard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (21) : 3069 - 3075
  • [40] Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion
    Jing Jian Sun
    Kang Wang
    Cun Zhen Zhang
    Wei Xing Guo
    Jie Shi
    Wen Ming Cong
    Meng Chao Wu
    Wan Yee Lau
    Shu Qun Cheng
    Annals of Surgical Oncology, 2016, 23 : 1344 - 1351
12345